v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 17,595 $ 26,701
General and administrative 17,565 6,590
Total operating expenses 35,160 33,291
Loss from operations (35,160) (33,291)
Other income (expense):    
Interest income 3,935 805
Change in fair value of warrant liabilities (188,360) 0
Total other (expense) income (184,425) 805
Net loss $ (219,585) $ (32,486)
Net loss per share attributable to common stockholders, basic [1] $ (5.11) $ (5.21)
Net loss per share attributable to common stockholders, diluted [1] $ (5.11) $ (5.21)
Weighted-average common shares outstanding, basic [1] 43,011,544 6,241,207
Weighted-average common shares outstanding, diluted [1] 43,011,544 6,241,207
Other comprehensive income (loss):    
Unrealized (loss) gain on available for sale marketable securities $ (747) $ 1
Total other comprehensive (loss) income: (747) 1
Comprehensive loss $ (220,332) $ (32,485)
[1] All share and per share amounts have been restated for prior periods on a retroactive basis to reflect a one-for-twenty reverse stock split effected in September 2025. See Note 2 for details.